受强制性开放获取政策约束的文章 - Yang ZHENG了解详情
可在其他位置公开访问的文章：14 篇
Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer
Y Zheng, Z Wang, S Wei, Z Liu, G Chen
Cancer letters 499, 148-163, 2021
强制性开放获取政策： 国家自然科学基金委员会
Ubiquitination and degradation of NF90 by Tim-3 inhibits antiviral innate immunity
S Dou, G Li, G Li, C Hou, Y Zheng, L Tang, Y Gao, R Mo, Y Li, R Wang, ...
Elife 10, e66501, 2021
强制性开放获取政策： 国家自然科学基金委员会
Tim-3 relieves experimental autoimmune encephalomyelitis by suppressing MHC-II
L Tang, G Li, Y Zheng, C Hou, Y Gao, Y Hao, Z Gao, R Mo, Y Li, B Shen, ...
Frontiers in Immunology 12, 770402, 2022
强制性开放获取政策： 国家自然科学基金委员会
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy
Y Bao, Y Qiao, JE Choi, Y Zhang, R Mannan, C Cheng, T He, Y Zheng, ...
Proceedings of the National Academy of Sciences 120 (49), e2314416120, 2023
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
T He, L Xiao, Y Qiao, O Klingbeil, E Young, XS Wu, R Mannan, ...
Cancer Cell 42 (8), 1336-1351. e9, 2024
强制性开放获取政策： Swiss National Science Foundation, Howard Hughes Medical Institute
Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection
Y Qiao, JW Wotring, CJ Zhang, X Jiang, L Xiao, A Watt, D Gattis, ...
PloS one 18 (2), e0281281, 2023
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity
JE Choi, Y Qiao, I Kryczek, J Yu, J Gurkan, Y Bao, M Gondal, JCY Tien, ...
Nature Communications 15 (1), 5487, 2024
强制性开放获取政策： Howard Hughes Medical Institute
Discovery of a first-in-class degrader for the lipid kinase PIKfyve
C Li, Y Qiao, X Jiang, L Liu, Y Zheng, Y Qiu, C Cheng, F Zhou, Y Zhou, ...
Journal of Medicinal Chemistry 66 (17), 12432-12445, 2023
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute, 国家自然 …
The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
Y Bao, G Cruz, Y Zhang, Y Qiao, R Mannan, J Hu, F Yang, M Gondal, ...
Cancer Discovery, OF1-OF19, 2024
强制性开放获取政策： Howard Hughes Medical Institute
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
T He, C Cheng, Y Qiao, H Cho, E Young, R Mannan, S Mahapatra, ...
Proceedings of the National Academy of Sciences 121 (15), e2322563121, 2024
强制性开放获取政策： Howard Hughes Medical Institute
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer
J Luo, Z Chen, Y Qiao, JCY Tien, E Young, R Mannan, S Mahapatra, T He, ...
bioRxiv, 2024.03. 29.587346, 2024
强制性开放获取政策： Howard Hughes Medical Institute
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
C Cheng, J Hu, R Mannan, R Bhattacharyya, NJ Rossiter, B Magnuson, ...
bioRxiv, 2024
强制性开放获取政策： Howard Hughes Medical Institute
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
Y Qiao, JW Wotring, Y Zheng, CJ Zhang, Y Zhang, X Jiang, CD Pretto, ...
Proceedings of the National Academy of Sciences 120 (30), e2221809120, 2023
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
PIKfyve controls dendritic cell function and tumor immunity
JE Choi, Y Qiao, I Kryczek, J Yu, J Gurkan, Y Bao, M Gondal, JCY Tien, ...
bioRxiv, 2024
强制性开放获取政策： Howard Hughes Medical Institute
出版信息和资助信息由计算机程序自动确定